|
251
|
|
|
CLN3 lysosomal/endosomal transmembrane protein, battenin |
BTN1, BTS, JNCL, SLC29B1 |
Anxiety disorder, Cataract, Cerebral atrophy, Concentric hypertrophic cardiomyopathy, Crohn disease, Dementia, Diabetes mellitus, Disorder of eye, Dysarthria, Esophagus neoplasm, Gastric cancer, Glaucoma, Age-related macular degeneration, Mental retardation, Neuronal ceroid lipofuscinosis, Optic atrophy, Parkinson disease, Psychosis, Retinitis pigmentosa, Rod-cone dystrophy, Stomach neoplasmsView all (6 more) |
|
252
|
|
|
Cytochrome P450 family 2 subfamily R member 1 |
- |
Dental enamel hypoplasia, Dwarfism, Frontal bossing, Hyperparathyroidism, Hypocalcemic seizures, Hypocalcemic vitamin d-dependent rickets, Liver cirrhosis, Liver fibrosis, Metabolic bone disorder, Motor delay, Osteopenia, Rachitic rosary, Rickets, Uveomeningoencephalitic syndrome, Vitamin d-dependent rickets |
|
253
|
|
|
CLN5 lysosomal BMP synthase |
- |
|
|
254
|
|
|
Chloride nucleotide-sensitive channel 1A |
CLCI, CLNS1B, ICln |
|
|
255
|
|
|
CLPTM1 regulator of GABA type A receptor forward trafficking |
- |
|
|
256
|
|
|
Clathrin light chain A |
LCA |
|
|
257
|
|
|
Clathrin light chain B |
LCB |
|
|
258
|
|
|
Clathrin heavy chain |
CHC, CHC17, CLH-17, CLTCL2, Hc, MRD56 |
Attention deficit hyperactivity disorder, Autism, Cerebral atrophy, Developmental delay, Developmental regression, Diffuse lymphoma, Dwarfism, Dyskinetic syndrome, Dysmorphic features, Epileptic encephalopathy, Gastroesophageal reflux disease, High palate, Hypodontia, Inflammatory myofibroblastic tumor, Mental retardation, Microcephaly, Movement disorders, Multiple congenital anomalies, Non-specifi epileptic encephalopathy, Non-syndromic intellectual disability, Nystagmus, Optic atrophy, Ptosis, Renal carcinoma, Status epilepticusView all (10 more) |
|
259
|
|
|
Chymase 1 |
CYH, MCT1, chymase |
|
|
260
|
|
|
Casein kinase 1 alpha 1 like |
CK1 |
|
